Beclomethasone Dipropionate Market

Global Beclomethasone Dipropionate Market Size, Share and Trend Analysis Report, By Application (Asthma and Allergic Rhinitis), By Route of Administration (Injection, Oral, and Inhalation), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025427 | Category : Pharmaceuticals | Delivery Format: /

The global beclomethasone dipropionate market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factor that is accelerating the growth of the market includes the rise in inflammatory-related symptoms among people. People living in industrial areas are more prone to developing asthma and allergic rhinitis, and beclomethasone dipropionate is used for the treatment of such diseases. Beclomethasone dipropionate is a synthetic corticosteroid drug used for controlling inflammatory symptoms such as sneezing, and shortness of breath. It is used by patients suffering from various inflammatory conditions including asthma, allergic rhinitis, and dermatoses. It is available in different formulations for its administration through oral, intranasal, and topical.

The global beclomethasone dipropionate market analysis includes some of the key market players such as Avik Pharmaceutical Ltd., Cipla Inc., and Teva Pharmaceutical Industries Ltd., among others. To maintain a strong position in the market, these market players are adopting various strategic moves, such as product launches, partnerships, collaborations, and mergers and acquisitions. For instance, in February 2018, Teva Pharmaceutical Industries Ltd. announced that QVAR RediHaler (beclomethasone dipropionate HFA) Inhalation Aerosol is commercially available to patients in both 40 mcg and 80 mcg strengths by prescription in the US.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: Avik Pharmaceutical Ltd., Cipla Inc., and Teva Pharmaceutical Industries Ltd., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Beclomethasone Dipropionate Market by Segment

By Application 

Asthma

Allergic Rhinitis

By Route of Administration 

Injection

Oral

Inhalation

Global Beclomethasone Dipropionate Market by Regional Analysis

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World